(3-((2-(Piperidin-1-yl)ethyl)carbamoyl)phenyl)boronic acid, 95.0%, 250mg

(S)-2-Methoxypropan-1-amine hydrochloride, 95.0%, 5g

O-(3-fluorobenzyl)hydroxylamine hydrochloride, 95%, 250mg

Ethyl 2-cyano-4,4-dimethoxybutanoate, 95.0%, 5g

Filtres pour seringues ROTILABO® Polytétrafluoroéthylène (PTFE), 0,45 µm, 15 mm, non stérile, 100 pièce(s)

(2E)-3-(4-chlorophenyl)-1-(2,4-dichlorophenyl)prop-2-en-1-one, 95.0%, 10g

(S)-3-((tert-Butoxycarbonyl)amino)-2-methylpropanoic acid, 95.0%, 250mg

(S)-SPINOL, 97%, 5g

N,N'-BIS(3-AMINOPROPYL)-1,3-PROPANEDIAMINE, 5g

1,2,4,5-Tetramethylimidazole>98.0%(GC)(T)100g

tert-Butyl 3-amino-5-nitro-1H-indazole-1-carboxylate, 95.0%, 1g

4-Pyridinepropanol>97.0%(GC)(T)25g

(R)-1-(3-Chloro-4-fluorophenyl)ethanamine hydrochloride, 95.0%, 25g